Cargando…
Herd immunity, vaccination and moral obligation
The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511978/ https://www.ncbi.nlm.nih.gov/pubmed/37277175 http://dx.doi.org/10.1136/jme-2022-108485 |
_version_ | 1785108264421163008 |
---|---|
author | Bullen, Matthew Heriot, George S Jamrozik, Euzebiusz |
author_facet | Bullen, Matthew Heriot, George S Jamrozik, Euzebiusz |
author_sort | Bullen, Matthew |
collection | PubMed |
description | The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd immunity threshold, at which models predict the decline of an epidemic; (2) the percentage of a population with immunity, whether it exceeds a given threshold or not; and/or (3) the indirect benefit afforded by collective immunity to those who are less immune. Moreover, the accumulation of immune individuals in a population can lead to two different outcomes: elimination (for measles, smallpox, etc) or endemic equilibrium (for COVID-19, influenza, etc). We argue that the strength of a moral obligation for individuals to contribute to herd immunity through vaccination, and by extension the acceptability of coercion, will depend on how ‘herd immunity’ is interpreted as well as facts about a given disease or vaccine. Among other things, not all uses of ‘herd immunity’ are equally valid for all pathogens. The optimal conditions for herd immunity threshold effects, as illustrated by measles, notably do not apply to the many pathogens for which reinfections are ubiquitous (due to waning immunity and/or antigenic variation). For such pathogens, including SARS-CoV-2, mass vaccination can only be expected to delay rather than prevent new infections, in which case the obligation to contribute to herd immunity is much weaker, and coercive policies less justifiable. |
format | Online Article Text |
id | pubmed-10511978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-105119782023-09-22 Herd immunity, vaccination and moral obligation Bullen, Matthew Heriot, George S Jamrozik, Euzebiusz J Med Ethics Original Research The public health benefits of herd immunity are often used as the justification for coercive vaccine policies. Yet, ‘herd immunity’ as a term has multiple referents, which can result in ambiguity, including regarding its role in ethical arguments. The term ‘herd immunity’ can refer to (1) the herd immunity threshold, at which models predict the decline of an epidemic; (2) the percentage of a population with immunity, whether it exceeds a given threshold or not; and/or (3) the indirect benefit afforded by collective immunity to those who are less immune. Moreover, the accumulation of immune individuals in a population can lead to two different outcomes: elimination (for measles, smallpox, etc) or endemic equilibrium (for COVID-19, influenza, etc). We argue that the strength of a moral obligation for individuals to contribute to herd immunity through vaccination, and by extension the acceptability of coercion, will depend on how ‘herd immunity’ is interpreted as well as facts about a given disease or vaccine. Among other things, not all uses of ‘herd immunity’ are equally valid for all pathogens. The optimal conditions for herd immunity threshold effects, as illustrated by measles, notably do not apply to the many pathogens for which reinfections are ubiquitous (due to waning immunity and/or antigenic variation). For such pathogens, including SARS-CoV-2, mass vaccination can only be expected to delay rather than prevent new infections, in which case the obligation to contribute to herd immunity is much weaker, and coercive policies less justifiable. BMJ Publishing Group 2023-09 2023-06-05 /pmc/articles/PMC10511978/ /pubmed/37277175 http://dx.doi.org/10.1136/jme-2022-108485 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Bullen, Matthew Heriot, George S Jamrozik, Euzebiusz Herd immunity, vaccination and moral obligation |
title | Herd immunity, vaccination and moral obligation |
title_full | Herd immunity, vaccination and moral obligation |
title_fullStr | Herd immunity, vaccination and moral obligation |
title_full_unstemmed | Herd immunity, vaccination and moral obligation |
title_short | Herd immunity, vaccination and moral obligation |
title_sort | herd immunity, vaccination and moral obligation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511978/ https://www.ncbi.nlm.nih.gov/pubmed/37277175 http://dx.doi.org/10.1136/jme-2022-108485 |
work_keys_str_mv | AT bullenmatthew herdimmunityvaccinationandmoralobligation AT heriotgeorges herdimmunityvaccinationandmoralobligation AT jamrozikeuzebiusz herdimmunityvaccinationandmoralobligation |